NAYA Biosciences Inc. (NAYA)
0.38
0.01 (2.70%)
At close: Mar 03, 2025, 3:59 PM
0.37
-1.43%
After-hours: Mar 03, 2025, 04:00 PM EST
Company Description
INVO Bioscience is a medical device company providing devices and products for infertility diagnosis.
Its flagship product is INVOcell, a reproductive technology that allows fertilization and early embryo development to take place within the woman’s body.
NAYA Biosciences Inc.
| Country | United States |
| IPO Date | Nov 2, 2020 |
| Industry | Medical/Nursing Services |
| Sector | Healthcare |
| Employees | 30 |
| CEO | Steven M. Shum |
Contact Details
Address: 5582 Broadcast Court Sarasota, United States | |
| Website | http://www.nayabiosciences.com |
Stock Details
| Ticker Symbol | n/a |
| Exchange | NASDAQ |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | n/a |
| ISIN Number | US44984F4019 |
| Employer ID | - |
| SIC Code | n/a |
Key Executives
| Name | Position |
|---|---|
| Steven M. Shum | Chief Executive Officer & Director |
| Andrea Goren | Chief Financial Officer |
| Anna Baran-Djokovic J.D. | Senior Vice President of Investor Relations |
| Dr. Daniel Gedeon Teper MBA, PharmD | President & Director |